WO2010122578A3 - Process for preparation of sitagliptin and its intermediates - Google Patents

Process for preparation of sitagliptin and its intermediates Download PDF

Info

Publication number
WO2010122578A3
WO2010122578A3 PCT/IN2010/000249 IN2010000249W WO2010122578A3 WO 2010122578 A3 WO2010122578 A3 WO 2010122578A3 IN 2010000249 W IN2010000249 W IN 2010000249W WO 2010122578 A3 WO2010122578 A3 WO 2010122578A3
Authority
WO
WIPO (PCT)
Prior art keywords
intermediates
sitagliptin
formula
improved processes
sitagliptin compound
Prior art date
Application number
PCT/IN2010/000249
Other languages
French (fr)
Other versions
WO2010122578A2 (en
Inventor
Manne Satyanarayana Reddy
Sajja Eswaraiah
Revu Satyanarayana
Bairy Kondal Reddy
Aluru Srinivas
Original Assignee
Msn Laboratories Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to IN901/CHE/2009 priority Critical
Priority to IN901CH2009 priority
Priority to IN2652/CHE/2009 priority
Priority to IN2652CH2009 priority
Priority to IN1084CH2010 priority
Priority to IN1084/CHE/2010 priority
Application filed by Msn Laboratories Limited filed Critical Msn Laboratories Limited
Publication of WO2010122578A2 publication Critical patent/WO2010122578A2/en
Publication of WO2010122578A3 publication Critical patent/WO2010122578A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Abstract

Improved processes for the preparation of Sitagliptin compound of formula-1 and its intermediates are provided.
PCT/IN2010/000249 2009-04-20 2010-04-20 Process for the preparation of sitagliptin and its intermediates WO2010122578A2 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IN901/CHE/2009 2009-04-20
IN901CH2009 2009-04-20
IN2652/CHE/2009 2009-11-03
IN2652CH2009 2009-11-03
IN1084/CHE/2010 2010-04-19
IN1084CH2010 2010-04-19

Publications (2)

Publication Number Publication Date
WO2010122578A2 WO2010122578A2 (en) 2010-10-28
WO2010122578A3 true WO2010122578A3 (en) 2010-12-29

Family

ID=43011552

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2010/000249 WO2010122578A2 (en) 2009-04-20 2010-04-20 Process for the preparation of sitagliptin and its intermediates

Country Status (1)

Country Link
WO (1) WO2010122578A2 (en)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101222679B1 (en) * 2009-10-21 2013-01-16 한미사이언스 주식회사 Method of preparing sitagliptin and intermediates used therein
WO2012046254A2 (en) * 2010-10-08 2012-04-12 Cadila Healthcare Limited Process for preparing an intermediate of sitagliptin via enzymatic conversion
CA2816000A1 (en) * 2010-11-11 2012-05-18 Redx Pharma Limited Drug derivatives
WO2012131005A1 (en) 2011-03-29 2012-10-04 Krka, Tovarna Zdravil, D.D., Novo Mesto Pharmaceutical composition of sitagliptin
EP2508506A1 (en) 2011-04-08 2012-10-10 LEK Pharmaceuticals d.d. Preparation of sitagliptin intermediates
CN102757431B (en) * 2011-04-24 2016-03-30 浙江华海药业股份有限公司 A kind of novel method of synthesizing sitagliptin
ITMI20110765A1 (en) * 2011-05-05 2012-11-06 Chemo Iberica Sa Process for the production of sitagliptin
EP2527320A1 (en) * 2011-05-27 2012-11-28 LEK Pharmaceuticals d.d. Preparation of Sitagliptin Intermediates
CN102838603B (en) * 2011-06-24 2015-05-13 上海医药工业研究院 Preparation method of intermediate compound of sitagliptin
WO2013001514A1 (en) 2011-06-29 2013-01-03 Ranbaxy Laboratories Limited Solid dispersions of sitagliptin and processes for their preparation
EP2726483A1 (en) 2011-06-30 2014-05-07 Ranbaxy Laboratories Limited Novel salts of sitagliptin
EP2736909B1 (en) 2011-07-27 2017-03-29 Farma GRS, d.o.o. Process for the preparation of sitagliptin and its pharmaceutically acceptable salts
CN102391142B (en) * 2011-09-30 2013-08-07 山东铂源药业有限公司 Method for recycling 3-(S)-amino-4-(2,4,5-trifluoro-phenyl)-butyrate
CN102503829B (en) * 2011-10-08 2013-11-06 山东铂源药业有限公司 Preparation methods for sitagliptin intermediates
WO2013065066A1 (en) 2011-11-02 2013-05-10 Cadila Healthcare Limited Processes for preparing 4-oxo-4-[3-(trifluoromethyl)-5,6- dihydro [l,2,41-triazolo[43-a]pyrazin-7(8h)-yl]-l-(2,4,5- trifluorophenyl)butan-2-amine
WO2013084210A1 (en) 2011-12-08 2013-06-13 Ranbaxy Laboratories Limited Amorphous form of sitagliptin salts
CN103172539B (en) * 2011-12-23 2016-08-03 上海阳帆医药科技有限公司 The preparation method of Glucovance sitagliptin intermediate aminobenzene butyric acid derivative
EP2674432A1 (en) 2012-06-14 2013-12-18 LEK Pharmaceuticals d.d. New synthetic route for the preparation of ß aminobutyryl substituted 5,6,7,8-tetrahydro[1,4]diazolo[4,3-alpha]pyrazin-7-yl compounds
AU2013301410A1 (en) 2012-08-08 2015-02-26 Cipla Limited Process for the preparation of sitagliptin and intermediate compounds
IN2013MU00916A (en) 2013-03-20 2015-06-26 Cadila Healthcare Ltd
CN104447374B (en) * 2013-09-17 2016-08-17 深圳翰宇药业股份有限公司 A kind of sitagliptin and the preparation method of intermediate thereof
CN103709170A (en) * 2014-01-14 2014-04-09 李友香 Medicinal crude drug for reducing blood sugar
CN103694245A (en) * 2014-01-14 2014-04-02 李友香 Crude medicine for hypoglycemic medicine
WO2015114657A2 (en) 2014-01-21 2015-08-06 Cadila Healthcare Limited Amorphous form of sitagliptin free base
EP3102580A4 (en) * 2014-02-05 2017-07-05 Stereokem Inc. (USA) Expedient synthesis of sitagliptin
WO2015145333A1 (en) 2014-03-26 2015-10-01 Sun Pharmaceutical Industries Limited Process for the preparation of sitagliptin and its intermediate
WO2015189862A1 (en) * 2014-06-10 2015-12-17 Council Of Scientific & Industrial Research Chiral amines, a process for preparation and use thereof
CN104130149B (en) * 2014-07-18 2016-01-27 浙江昌明药业有限公司 A kind of recoverying and utilizing method of 3-(S)-amino butyric acid derivative
CN104130264B (en) * 2014-08-14 2016-08-31 广东东阳光药业有限公司 A kind of method for transformation of isomer
CN104387393A (en) * 2014-10-31 2015-03-04 广东东阳光药业有限公司 Preparation method of sitagliptin impurity
AU2015376077A1 (en) * 2015-01-08 2017-07-27 Lee Pharma Limited Novel process for the preparation of dipeptidyl peptidase-4 (DDP-4) enzyme inhibitor
CN105017081B (en) * 2015-07-08 2017-03-08 和鼎(南京)医药技术有限公司 A kind of preparation method of sitagliptin intermediate
CN105085531B (en) * 2015-09-06 2017-11-17 合肥华方医药科技有限公司 A kind of Xi Gelieting impurity synthetic method
CN105218371A (en) * 2015-09-24 2016-01-06 上海交通大学 The preparation method of optically pure 3-hydroxyl-4-(2,4,5-trifluorophenyl) ethyl butyrate
CN105130999B (en) * 2015-10-15 2017-10-20 合肥华方医药科技有限公司 A kind of synthetic method of Xi Gelieting impurity
CN105331651B (en) * 2015-11-25 2018-11-13 尚科生物医药(上海)有限公司 The enzyme-chemically preparation method of sitagliptin and its intermediate
US10047094B1 (en) * 2017-02-10 2018-08-14 F.I.S.—Fabbrica Italiana Sintetici S.p.A. Process for the preparation of triazole and salt thereof
CN109867659A (en) * 2017-12-04 2019-06-11 江苏恒瑞医药股份有限公司 The preparation method of benzo piperidine derivatives
CN108178761A (en) * 2017-12-28 2018-06-19 安庆奇创药业有限公司 A kind of synthetic method of Xi Gelieting

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1524082A (en) * 2001-07-06 2004-08-25 麦克公司 Beta-amino tetrahydroimidazo (1,2-a) pyrazines and ahydrotrioazolo (4,3-a) pyrazines as dipeptidyl idase inhibitors for the treatment or prevention of diabetes
CN1832949A (en) * 2003-06-24 2006-09-13 麦克公司 Phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1524082A (en) * 2001-07-06 2004-08-25 麦克公司 Beta-amino tetrahydroimidazo (1,2-a) pyrazines and ahydrotrioazolo (4,3-a) pyrazines as dipeptidyl idase inhibitors for the treatment or prevention of diabetes
CN1832949A (en) * 2003-06-24 2006-09-13 麦克公司 Phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
AHN JIN HEE ET AL.: "Synthesis, Biological Evaluation And Structural Determination Of beta- minoacyl-containing Cyclic Hydrazine Derivatives As Dipeptidyl Peptidase IV (DPP-IV) nhibitors.", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 17, 2007, pages 2622 - 2628 *

Also Published As

Publication number Publication date
WO2010122578A2 (en) 2010-10-28

Similar Documents

Publication Publication Date Title
HRP20161648T1 (en) Processes for the preparation of sglt2 inhibitors
HRP20151133T1 (en) Compounds for the reduction of beta-amyloid production
HK1219741A1 (en) Method for the production of domain antibodies
IL238337D0 (en) Process for the manufacture of pharmaceutically active compounds
HK1170241A1 (en) Process for the preparation of compounds useful as inhibitors of sglt2 sglt2
HRP20130456T1 (en) Novel process for the preparation of amino acid derivatives
WO2012014076A3 (en) Liver organoid, uses thereof and culture method for obtaining them
WO2012107778A3 (en) Mutant pores
WO2011138281A3 (en) Process for the preparation of dithiine tetracarboxydiimides
PT2913337T (en) Process for the production of sofosbuvir
PL2349962T3 (en) Process for the manufacture of hydrochlorofluoroolefins
EP2285973A4 (en) Microorganisms for the production of methacrylic acid
PT2379730E (en) Method for the preparation of diols
WO2008025856A3 (en) Modified glycoproteins
WO2009036281A3 (en) Bortezomib and process for producing same
WO2011055231A3 (en) Rebaudioside a polymorphs and methods to prepare them
BRPI1008021A2 (en) Method for the manufacture of 2,6-dioxabicyclo- (3.3.0) -octane-4,8-dione
ZA201201874B (en) Process for the production of butadiene
EP2457908B8 (en) Process for the Preparation of Compounds useful as inhibitors of SGLT
EP2347018A4 (en) Process for production of direct reduced iron
PL2630108T3 (en) Process for the preparation of 2,3,3,3 tetrafluoropropene
AT533775T (en) Process for the preparation of 17-vinyl-triflates as intermediates
PL2281792T3 (en) Process for the preparation of fluorinated compounds
HK1152078A1 (en) Production of squalene from hyper-producing yeasts
BRPI1011672A2 (en) process for the preparation of cyclohexanone phenol

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10766754

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10766754

Country of ref document: EP

Kind code of ref document: A2